Contemporary prenatal aneuploidy screening practice in Australia: Frequently asked questions in the cell-free DNA era

Wawrzyniec Rieder, Scott White, George McGillivray, Lisa Hui

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cell-free DNA screening has quickly become established in Australia as an accurate – albeit costly – prenatal screening test for trisomy 21, 18 and 13. It is also commonly used for the detection of sex chromosome abnormalities. The increasing number of prenatal screening pathways available to women has increased the complexity of pretest counselling. Concurrent advances in diagnostic testing with the widespread use of chromosomal microarrays create further challenges for the continuing education of clinicians and health consumers. This article aims to answer common clinical questions in this rapidly evolving field and complements the recently updated Royal Australian and New Zealand College of Obstetricians and Gynaecologists Statement on Prenatal Screening for Fetal Chromosome and Genetic Conditions.

Original languageEnglish
Pages (from-to)397-403
Number of pages7
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume58
Issue number4
DOIs
Publication statusPublished - 1 Aug 2018

Fingerprint Dive into the research topics of 'Contemporary prenatal aneuploidy screening practice in Australia: Frequently asked questions in the cell-free DNA era'. Together they form a unique fingerprint.

  • Cite this